BioCryst Pharmaceuticals | Netto Inntekt

Net Income Endring Dato
Gilead Sciences USD 1.43B 751M 2023-12
Intra Cellular Therapies USD -28579000 4.32M 2023-12
Ionis Pharmaceuticals USD -9263000 138.15M 2023-12
Roche Holding CHF 7.14B 3.25B 2023-06
Ultragenyx Pharmaceutical USD -123190000 36.46M 2023-12
Vertex Pharmaceuticals USD 1.04B 119.6M 2023-09



BioCryst Pharmaceuticals Netto Inntekt - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2024.